Sybrava Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing Brand Resources

Concise Prescribing Info

Contents

Inclisiran

Indications/Uses

Primary hypercholesterolaemia (heterozygous familial & non-familial) or mixed dyslipidaemia as adjunct to diet in combination w/ statin or statin w/ other lipid-lowering therapies in patients unable to reach LDL-C goals w/ max tolerated dose of statin; or as monotherapy or in combination w/ other lipid-lowering therapies in patients who are statin-intolerant or whom statin is contraindicated.

Click to view Sybrava detailed prescribing information

Dosage/Direction for Use

SC Recommended dose: Initially 284 mg as single SC inj into abdomen, thigh or upper arm. Repeat at 3 mth, followed by every 6 mth.

Click to view Sybrava detailed prescribing information

Overdosage

View Sybrava overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity.

Click to view Sybrava detailed prescribing information

Special Precautions

Not to be given into areas of active skin disease or injury (eg, sunburns, skin rashes, inflammation or infections). Not to perform haemodialysis for at least 72 hr after treatment. Severe hepatic impairment (Child-Pugh class C). Avoid use during pregnancy. Lactation. Childn <18 yr.

Click to view Sybrava detailed prescribing information

Use In Pregnancy & Lactation

Click to view Sybrava detailed prescribing information

Adverse Reactions

Inj site reaction.

Click to view Sybrava detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Sybrava detailed prescribing information

Storage

View Sybrava storage conditions for details to ensure optimal shelf-life.

Description

View Sybrava description for details of the chemical structure and excipients (inactive components).

Action

View Sybrava mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Dyslipidaemic Agents

ATC Classification

C10AX16 - inclisiran ; Belongs to the class of other lipid modifying agents.

Thai FDA Category

Presentation/Packing

Form

Sybrava soln for inj 284 mg/1.5 mL

Packing/Price

1's

Sybrava

inclisiran

Manufacturer:

Novartis

Distributor:

Zuellig Pharma

Marketer:

Novartis